Sign in

CIK 0001599298

  • Large accelerated filer

Summit Therapeutics Inc.

Sign in to watch
Ticker
SMMT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
371979717
Phone
+1 305-203-2034
Business address
601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
Former names
Summit Therapeutics plc, Summit Corp plc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-10-08 Anand Bhaskar Chief Accounting Officer Grant or award +100,000 261,047
2026-01-08 Anand Bhaskar Chief Accounting Officer Grant or award · Stock Option (right to buy) +30,000 30,000
2025-10-21 Anand Bhaskar Chief Accounting Officer Grant or award +26,680 $18.74 $500K 159,751
2025-09-18 Anand Bhaskar Chief Accounting Officer Grant or award · Stock Option (right to buy) +50,000 50,000
2025-04-29 Anand Bhaskar Chief Accounting Officer Grant or award · Stock Option (right to buy) +600,000 600,000
2025-04-29 Anand Bhaskar Chief Accounting Officer Grant or award · Stock Option (right to buy) +75,000 75,000
2025-01-12 Anand Bhaskar Chief Accounting Officer Grant or award · Stock Option (right to buy) +75,000 75,000
2024-09-11 Anand Bhaskar Chief Accounting Officer Grant or award +22,026 $22.70 $500K 131,426
2024-04-02 Anand Bhaskar Chief Accounting Officer Grant or award · Stock Option (right to buy) +600,000 600,000

Page 1 of 1 · 9 trades